The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


DRYNOL

20 Milligram Tablets

PCO ManufacturingPPA0465/424/001

Main Information

Trade NameDRYNOL
Active SubstancesBILASTINE
Strength20 Milligram
Dosage FormTablets
Licence HolderPCO Manufacturing
Licence NumberPPA0465/424/001

Group Information

ATC CodeR06AX29 bilastine

Status

Authorised/WithdrawnAuthorised
Licence Issued01/03/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back